pfizer biontech - Search News

News

Pfizer raises 2025 profit forecast

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer raised its full-year profit forecast on Tuesday while reporting second-quarter results that topped Wall Street estimates, and said it expects to benefit from further cost-cutting across its research and manufacturing operations.

Bloomberg on MSN · 3h

Pfizer Raises Profit View as Cost Cuts Offset Poor Sales Growth

Pfizer Inc. raised its profit forecast for the year with the drugmaker’s ongoing cost cuts helping to make up for a lack of sales growth.

CNBC on MSN · 4h

Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results

The results come as Pfizer and other drugmakers grapple with Trump's calls to lower U.S. drug prices and brace for his planned tariffs on pharmaceuticals.

Pfizer rises

Seeking Alpha on MSN · 4h

Pfizer rises as Q2 beat leads to guidance raise

Pfizer (NYSE:PFE) shares traded higher in the premarket on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook,

InvestorsHub on MSN · 2h

Pfizer lifts 2025 profit forecast after strong Q2 beats, shares rise

Pfizer (NYSE:PFE) raised its full-year earnings outlook on Tuesday after reporting second-quarter results that surpassed Wall Street expectations, driving its shares up more than 3% in premarket trading.

AOL · 4h

Pfizer beats in Q2 earnings, reaffirms 2025 outlook

Pfizer has been in a cycle of right-sizing its business after the outsized COVID-19 profits boosted the company's coffers and stock for several quarters. Since the waning of the pandemic, and recent signals from U.

20h

UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

3don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

BioSpace1d

BioNTech Commits to Infectious Diseases Amid Questions Over Vaccine Demand

The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...

The Manila Times on MSN2d

Pfizer and BioNTech lose UK court appeal over Covid-19 jab

Pfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at ...

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...

BioSpace4d

Moderna Wins UK Patent Battle Against Pfizer and BioNTech

A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.

TheHealthSite on MSN15d

Pfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?

BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...

5don MSN

Where Will Pfizer (PFE) Be in 5 Years?

Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results